NOVATO, CA – Biosearch Technologies, Inc. (Biosearch), a leading supplier of sophisticated oligonucleotide components to the rapidly growing molecular diagnostics industry, today announced that Uniscience is the new distributor authorized to sell, market, and support Biosearch’s inventoried and custom products in the country of Brazil. A few product lines in which Uniscience will focus their […]

BRANFORD, Conn., — HistoRx, the leader in quantitative immunohistochemistry, announces the application of their proprietary AQUA technology to assessment of messenger RNA in tissue. AQUA technology enables robust quantification and standardization of protein in tissue specimens; this new work extends the platform’s capabilities beyond protein expression analysis to quantification of nucleic acids. AQUA technology was […]

OMAHA, Neb. – Transgenomic, Inc. (OTC/BB: TBIO) today announced it has achieved CE IVD Mark registration in Europe for the diagnostic use of its proprietary WAVE MCE System and SURVEYOR® Scan KRAS Kit. Analysis of the KRAS gene is critical for treatment decision-making in many cancer types. Gaining the CE IVD Mark enables diagnostic product […]

FAIRFIELD, Conn.–GE announced today that Sue Siegel has been named a GE Corporate Vice President and will serve as CEO of healthymagination, GE’s $6 billion global commitment to provide better health for more people by lowering costs and increasing access. “Sue Siegel’s great passion for advancing healthcare is matched by her keen understanding of innovation, […]

SALT LAKE CITY, — Lineagen today announced the Company completed the testing portion of a 9,000-person research study designed to confirm novel copy number genetic variants and novel next-generation sequence variants associated with autism spectrum disorder (ASD). These variants were discovered by Hakon Hakonarson, M.D., Ph.D., and his team at The Children’s Hospital of Philadelphia […]

Agilent Technologies Inc. (NYSE: A) and EQT, the Sweden-based private equity group, today announced the execution of a definitive agreement for Agilent to acquire Dako, the Denmark-based cancer diagnostic company. The $2.2 billion acquisition (on a debt-free basis) is the largest in Agilent’s history. “In the rapidly growing diagnostics market, Dako’s products and capabilities are […]

MADISON, N.J., — Quest Diagnostics (NYSE: DGX), the world’s leading provider of diagnostic testing, information and services, has extended its endocrine diagnostics menu with the introduction of four new tests panels for congenital adrenal hyperplasia (CAH), an endocrine disorder found in newborns, children and women. The panels are designed to overcome limitations in conventional testing […]

SEATTLE — NanoString Technologies, Inc., a privately held provider of life science tools for translational research and developer of molecular diagnostics, today announced the initiation of the second clinical validation study of its PAM50-based breast cancer assay. The new study will evaluate samples from more than 1,000 patients enrolled in the Austrian Breast & Colorectal […]

INDIANAPOLIS, — HYCOR Biomedical, Inc., a leading manufacturer of diagnostic products, and Roche today announced the signing of a global distribution agreement of KOVA® urinalysis products. As part of the agreement, Roche will distribute KOVA urinalysis plastics and controls products with its urinalysis tests and platforms worldwide for the next five years. “Concurrent with our […]